source
- STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and moreThe 17 pharmaceutical companies anchoring TrumpRx poured more than $130 million into federal lobbying in 2025 — a nearly 23% surgeSTAT · 2mo ago↗ source
- GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026We spoke with leading voices in GU oncology to see which presentations they are most looking forward to during the 2026 ASCO Annual Meeting.onclive · 2mo ago↗ source
- Unmet Needs in Endometrial CancerImportant unmet needs remain in endometrial cancer even as antibody drug conjugates begin to expand the therapeutic armamentarium.onclive · 2mo ago↗ source